Iranian Journal of Medical Sciences

Document Type : Letter(s) to the Editor


1 Department of Dermatology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Department of Dermatology, Skin and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

3 Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran

4 Department of Dermatology Skin Diseases and Leishmaniasis Research Center School of Medicine Isfahan University of Medical Sciences Isfahan Iran



Hair loss, which is known as telogen effluvium (TE), was reported in COVID-19 patients both during and after their recovery.


  1. Hussain N, Agarwala P, Iqbal K, Omar HMS, Jangid G, Patel V, et al. A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation. J Med Virol. 2022;94:1391-401. doi: 10.1002/jmv.27534. PubMed PMID: 34931698.
  2. Sharquie KE, Jabbar RI. COVID-19 infection is a major cause of acute telogen effluvium. Ir J Med Sci. 2022;191:1677-81. doi: 10.1007/s11845-021-02754-5. PubMed PMID: 34467470; PubMed Central PMCID: PMCPMC8407603.
  3. Seyfi S, Alijanpour R, Aryanian Z, Ezoji K, Mahmoudi M. Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity. J Med Life. 2022;15:631-4. doi: 10.25122/jml-2021-0380. PubMed PMID: 35815081; PubMed Central PMCID: PMCPMC9262270.
  4. Torres F, Tosti A. Female pattern alopecia and telogen effluvium: figuring out diffuse alopecia. Semin Cutan Med Surg. 2015;34:67-71. doi: 10.12788/j.sder.2015.0142. PubMed PMID: 26176282.
  5. Miola AC, Florencio LC, Bellini Ribeiro ME, Alcantara GP, Muller Ramos P, Miot HA. Early-onset effluvium secondary to COVID-19: Clinical and histologic characterization. J Am Acad Dermatol. 2022;86:e207-e8. doi: 10.1016/j.jaad.2021.09.072. PubMed PMID: 34906662; PubMed Central PMCID: PMCPMC8665661.